Trae Fitzgerald - 17 Jan 2025 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Role: Chief Financial Officer
Signature: /s/ Jesse Bergeron, Attorney-in-Fact
Issuer symbol: VMD
Transactions as of: 17 Jan 2025
Transactions value $: -$74,947
Form type: 4
Filing time: 22 Jan 2025, 18:40:00 UTC
Previous filing: 10 May 2024
Next filing: 23 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VMD	Common Shares	Options Exercise		+9,591	+14%		76,019	17 Jan 2025	Direct	F1
transaction	VMD	Common Shares	Tax liability	-$27,873	-3,420	-4.5%	$8.15	72,599	17 Jan 2025	Direct	F2, F3
transaction	VMD	Common Shares	Options Exercise		+2,398	+3.3%		74,997	17 Jan 2025	Direct	F4
transaction	VMD	Common Shares	Disposed to Issuer	-$19,543	-2,398	-3.2%	$8.15	72,599	17 Jan 2025	Direct	F3
transaction	VMD	Common Shares	Options Exercise		+3,378	+4.7%		75,977	18 Jan 2025	Direct	F4
transaction	VMD	Common Shares	Disposed to Issuer	-$27,530	-3,378	-4.4%	$8.15	72,599	18 Jan 2025	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VMD	Restricted Stock Units	Options Exercise	$0	-9,591	-50%	$0	9,590	17 Jan 2025	Common Shares	9,591		Direct	F1, F5
transaction	VMD	Phantom Share Units	Options Exercise		-2,398	-50%		2,397	17 Jan 2025	Common Shares	2,398		Direct	F4, F6
transaction	VMD	Phantom Share Units	Options Exercise		-3,378	-100%		0	18 Jan 2025	Common Shares	3,378		Direct	F4, F7
transaction	VMD	Restricted Stock Units	Award	$0	+39,949		$0	39,949	21 Jan 2025	Common Shares	39,949		Direct	F1, F8
transaction	VMD	Phantom Share Units	Award	$0	+9,987		$0	9,987	21 Jan 2025	Common Shares	9,987		Direct	F9, F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F2	Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
F3	Per share value is based on the market closing price of the common shares for January 17, 2025.
F4	Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F5	Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F6	Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
F7	Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
F8	Restricted Stock Units (RSUs) granted to reporting person on January 21, 2025, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F9	Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
F10	Represents an award granted on January 21, 2025 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.